Effects of Incorporating Sprouted and Non-sprouted Chickpea Flour in Pasta Products Analyzed in Vivo Flow-mediated Dilation - Trial NCT03801486
Access comprehensive clinical trial information for NCT03801486 through Pure Global AI's free database. This phase not specified trial is sponsored by Montclair State University and is currently Completed. The study focuses on Endothelial Dysfunction. Target enrollment is 34 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Montclair State University
Timeline & Enrollment
N/A
Mar 02, 2016
May 01, 2017
Primary Outcome
Post-digestion flow mediated dilation
Summary
The investigators examined the effects on post-digestion brachial artery flow mediated
 dilation (FMD) and in vitro antioxidant capacity of 40% semolina flour replacement with
 sprouted chickpea flour.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03801486
Non-Device Trial